Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/119365
Title: Type 2 amiodarone-induced thyrotoxicosis in a patient with positive thyroid-stimulating hormone-receptor antibodies
Authors: Piscopo, Naomi
Soler, Samuel F.
Mifsud, Simon
Vella, Sandro
Keywords: Amiodarone
Hyperthyroidism
Thyrotropin
Hormone receptors
Issue Date: 2023
Publisher: MA Healthcare Ltd
Citation: Piscopo, N., Soler, S. F., Mifsud, S., & Vella, S. (2023). Type 2 amiodarone-induced thyrotoxicosis in a patient with positive thyroid-stimulating hormone-receptor antibodies. British Journal of Hospital Medicine, 84(2), 1-3.
Abstract: The authors present a case of type 2 amiodarone-induced thyrotoxicosis in a 55-year-old man with positive thyroid-stimulating hormone-receptor antibodies, who had not been taking amiodarone for 8months. This case highlights that the presence of thyroid-stimulating hormone-receptor antibodies does not necessarily imply the development of Graves’ disease. It also demonstrates that amiodarone-induced thyrotoxicosis can present several months after withdrawal of amiodarone treatment. In this case, the rapid and dramatic drop in free triiodothyronine levels with glucocorticoid therapy suggested type 2 amiodarone-induced thyrotoxicosis.
URI: https://www.um.edu.mt/library/oar/handle/123456789/119365
Appears in Collections:Scholarly Works - FacM&SMed



Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.